Akari Therapeutics Announces Completion of Phase II COBALT Trial of Coversin in Patients with PNH Biotech Investing
BioDelivery Sciences Announces BELBUCA® Patent Litigation Settlement Agreement with Teva Biotech Investing
Phivida Appoints Former Senior Executive Officer of Red Bull, Samsung, Microsoft as New Chief Marketing Officer Biotech Investing
Capricor Receives FDA Regenerative Medicine Advanced Therapy Designation for Duchenne Muscular Dystrophy Therapy Biotech Investing
Sorrento’s and Yuhan’s Joint Venture, ImmuneOncia, receives Approval to begin clinical trial of Anti-PD-L1 Biotech Investing
